Awareness about health, diet, and nutrition among the general public has precipitated a plethora of technology driven solutions to track of diet and calorie intake. Although this has helped a large population to better understand their calorie intake, it has failed to serve the needs of population battling eating disorders.
10 – 15%
Americans battle with eating disorders
1 in 10
Individuals with eating disorders receive treatment
Average costs of 4 month treatment
Lumme’s platform is specifically designed to be scalable, adaptable, accessible, and seamlessly integrate with the patient’s daily life. First, we identifying hand-to-mouth gestures using the smartwatch. Then we identify healthy and unhealthy eating associated with these gestures using context such as pace of eating, time and duration of the meal, frequency of meals, activities prior to and after eating, and location.
Preliminary results show that Lumme’s platform can detect eating gestures with an accuracy of 91%. Overall,this platform would immensely aid in improving patient engagement, reduce treatment costs, and improving treatment outcomes.
Alcohol use is one of the leading causes of preventable death in the United States. Understanding alcohol addiction among individuals in their natural settings is severely curbed by shortcomings of existing systems.
Deaths per year in the US
1 in 3
Liver transplants due to alcohol addiction
Lumme is developing a behavioral tracking device that can be used in tandem with transdermal alcohol sensors to address many of these limitations. The Lumme system combines the use of a smartwatch and smartphone to assess drinking behavior in real time. The combined system can accurately track important drinking variables of interest to researchers and clinicians (e.g., time of drinking, length of drinking episode, rate of drinking, resulting BAC). Additionally, the gesture data will also remotely capture low level drinking episodes that are undetected by existing systems. This work is funded through an SBIR grant from the National Institutes of Alcohol Abuse and Alcoholism.
Obesity related disorders
Individuals who are overweight or obese have an elevated risk of developing coronary heart disease, high blood pressure, stroke, type 2 diabetes, metabolic syndrome, cancer, sleep apnea, and osteoarthritis. Lumme’s platform can help individuals understand their overall eating behavior and triggers associated with unhealthy eating habits.
Americans considered to be overweight or obese
1 in 3
Children aged 6-19 are overweight or obese in the US
Annual health care costs associated with obesity
For individuals with severe obesity, treatments with diet and exercise alone are insufficient while bariatric surgery has proven to be effective. However, the effectiveness and long term benefits of surgery depends heavily on the patient’s compliance to post-operative recommendations. Lumme’s automated software platform can help patients monitor their dietary regimen, smoking cessation program, fluid intake, and activity levels. This platform also allows healthcare providers, therapists, and nutritionists to monitor compliance among patient population after their surgery.
Bariatric surgeries per year
49 – 73%
Success rates after surgery
Reduction in risk of mortality after surgery